• Mashup Score: 0

    While you might think frequent ear blocks are a usual problem and there’s not much to think about. However, this is a symptom of a type of cancer; Nose or Sinus Cancer. For early detection to be possible, it is important that you know the symptoms. Read on to know the signs and symptoms of nose cancer. , Health News, Times Now

    Tweet Tweets with this article
    • While you might think a frequent ear blockage is nothing to worry about. However, it might be a sign of nose or sinus cancer. Read more about these symptoms here.. . . . . #Maxlajpatnagar #nosecancer #cancersymptoms #cancerawareness #CancerInformation https://t.co/tvy9Ie5BZN

  • Mashup Score: 0
    Multiple Myeloma Hub - 2 year(s) ago

    The Multiple Myeloma Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in multiple myeloma. Our aim is to enhance knowledge in multiple myeloma through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management. The Multiple Myeloma Hub shares new data, evidence-based…

    Tweet Tweets with this article
    • πŸŽ₯ Have you visited our YouTube Channel? To view the latest topics of discussion and expert opinions on multiple myeloma, visit: https://t.co/utsABJsMeR #mmsm #cancerawareness https://t.co/nK9tn3MoBK

  • Mashup Score: 0

    Cancer Today, a website and magazine published by the American Association for Cancer Research, selects a new book every quarter that aims to deepen understanding of cancer. Patients, caregivers and…

    Tweet Tweets with this article
    • Pleased that my book will provide fodder ; ) for this summer's @CancerTodayMag's book group @facebook https://t.co/wDNlKU89iT. I enjoy speaking with #bookgroups, btw, happy to discuss #FromWhispersToShouts. Reviews welcome! https://t.co/LCtK6KvvDu #cancerawareness #history https://t.co/bpU5217nCY

  • Mashup Score: 0

    During the steering committee meeting, members discussed the advantages, disadvantages, and important considerations when choosing between continuous and time-limited therapies in both CLL and lymphoma.

    Tweet Tweets with this article
    • 🚨Another interesting discussion with our steering committee is on the @LymphomaHub Topic: Time-limited therapy for CLL and lymphoma – who, what, how? Chaired by: Francesc Bosch (@Sidnavigare) Watch here:πŸ‘‰ https://t.co/i6ktUUrRUI πŸ‘ˆ #lymsm #cancertreatment #cancerawareness https://t.co/H3kUwyvTb1

  • Mashup Score: 0

    The Lymphoma Hub Steering Committee discuss how the treatment of patients with DLBCL varies in different countries, with a focus on the current use of clinical pathology for the diagnosis of subtypes and how this has an influence on determining first-line therapy, particularly in selecting treatment choices in patients without significant comorbidities.

    Tweet Tweets with this article
    • We recently hosted an #expertdiscussion on the important theme of: How I treat newly diagnosed DLBCL Led by @LymphomaHub Steering Committee Chair, Gilles Salles (@gilles_salles). Watch here: πŸ‘‰ https://t.co/zg97UQwUbS πŸ‘ˆ #lymsm #cancertreatment #cancerawareness #IME https://t.co/5b2AwkZakR